Award
NIH Reporter #1R21AG101719-01
Defining the Mechanisms Underlying the Protective Effects of the Reelin-COLBOS Variant in Alzheimer's Disease (AD)
Recipient
Arizona State University - Tempe Campus
Award Amount
$431,750.00
Ceiling
$431,750.00
Awarded
August 28, 2026
Identifier
1R21AG101719-01
NIH awarded $431,750 to Arizona State University for research on the neuroprotective mechanisms of the RELN-COLBOS variant in Alzheimer's disease, using genome editing and stem cell models, from 2026 to 2028.
Description
This NIH-funded project aims to elucidate the neuroprotective mechanisms of the RELN-COLBOS variant in Alzheimer’s disease using genome editing and stem cell models. The project is led by Dr. David A. Brafman at Arizona State University, with a budget of $431,750, spanning from September 2026 to August 2028.